(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

COMPOSTO, FORMULAÇÃO FARMACÊUTICA, PROCESSO PARA INIBIR 5ALFA-REDUCTASE, PROCESSOS PARA TRATAR HIPERPLASIA BENIGNA DA PRÓSTATA, SEBORRÉIA E ALOPECIA ANDROGÊNICA

ArquivadaInvention Patent

Application data

Number

PI9203266

Type

Invention Patent

Filing

08/21/1992

Publication

04/06/1993

Progress at the INPI

  1. Filing08/21/92
  2. Publication04/06/93
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 08/21/1992 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 10/03/1995. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

Eli Lilly and Company

US

See this company's full portfolio

Inventors

C. J. (pessoa física)

US

K. H. (pessoa física)

US

Technical data

IPC Classification

Priority claims

US

748.134 · 08/21/1991

US

780.166 · 10/21/1991

Abstract

A invenção se refere a 1,2,3,4,5,6-hexa-hidrobenzo[f]quinolin-3-onas, formulações farmacêuticas contendo estes compostos, e seu uso como inibidores de 5alfa-reductase esteróides.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento - Art. 33 da LPI

#11.1

10/03/1995

RPI 1296

Publicação do pedido de patente

#3.1

04/06/1993

RPI 1166

Pedido de patente depositado

#2.1

09/29/1992

RPI 1139

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.